Qianhai Health Holdings Limited (HKG:0911)

Market Cap	123.69M +256.1%
Revenue (ttm)	677.12M +30.3%
Net Income	5.94M +353.2%
EPS	0.04 +353.2%
Shares Out	169.45M
PE Ratio	20.82
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	780,125
Open	0.7400
Previous Close	0.7500
Day's Range	0.6500 - 0.7500
52-Week Range	0.1800 - 1.4000
Beta	1.55
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 3, 2026

About Qianhai Health Holdings

Qianhai Health Holdings Limited, an investment holding company, engages in the trading and sale of electronic components, and health-care products and food businesses in Hong Kong. It offers Chinese herbal medicines and other health care products; and administrative services. The company also sells health beverages, ginseng wine, and skin-care products. In addition, it is involved in the sale of information technology component products, including NAND flash wafer, a thin slice of semiconductor material, such as silicon, a component of flash me...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 19
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0911

Financial Performance

In 2025, Qianhai Health Holdings's revenue was 677.12 million, an increase of 30.29% compared to the previous year's 519.70 million. Earnings were 5.94 million, an increase of 353.17%.